Diagnosed too lateDecember 6, 2022Patient & Survivor CareRenal Cell CarcinomaPreventive CarePractice ManagementMixed TopicsMetastatic Breast CancerMelanoma
Atezolizumab (Tecentriq) bladder cancer indication withdrawn in United StatesDecember 1, 2022Genitourinary Cancer
Discontinuing immunotherapy: Is the infusion bag half empty or half full?November 23, 2022Lung CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersImmuno-oncology
How AI is, or will soon be, relevant in radiation oncologyNovember 13, 2022Lung CancerBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
Chronic stress, especially race related, may hasten cancer deathNovember 13, 2022Diversity in MedicineGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Third COVID booster benefits cancer patientsNovember 12, 2022COVID-19 UpdatesBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersLung Cancer
$38,398 for a single shot of a very old cancer drugOctober 27, 2022Genitourinary CancerPatient & Survivor CarePractice Management
Is early-onset cancer an emerging global epidemic?October 5, 2022Preventive CareBreast CancerHead & Neck/Thyroid CancersGastrointestinal CancerGenitourinary CancerRenal Cell Carcinoma
Cancer as a full contact sportOctober 3, 2022Patient & Survivor CarePractice ManagementRenal Cell CarcinomaMetastatic Breast CancerMixed TopicsMelanomaLung Cancer
Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerHead & Neck/Thyroid CancersMelanomaGastrointestinal CancerGenitourinary Cancer
High BMI linked to better survival for cancer patients treated with ICI, but for men onlySeptember 22, 2022Lung CancerBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022Gastrointestinal CancerPractice ManagementMixed TopicsBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic Cancer
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
The ‘great dynamism’ of radiation oncologyAugust 18, 2022Lung CancerMixed TopicsBreast CancerHead & Neck/Thyroid CancersGenitourinary Cancer
